MWA
ANIP icon

Moser Wealth Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Moser Wealth Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$979 Hold
15
– – ﹤0.01% 192
2025
Q1 		$1K Buy
+15
New +$896 ﹤0.01% 157

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Moser Wealth Advisors's ANIP Position: Q2 2025 in Review

Moser Wealth Advisors held its ANI Pharmaceuticals (ANIP) position steady in Q2 2025 at 15 shares worth $979. The position accounts for ﹤0.01% of the portfolio, ranked #192.

Moser Wealth Advisors first reported a position in ANIP in Q1 2025 and has held it in 2 quarters since. The position peaked at $1K in Q1 2025. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.

  • Moser Wealth Advisors held 15 shares of ANI Pharmaceuticals worth $979 as of Q2 2025.
  • Moser Wealth Advisors left its ANI Pharmaceuticals share count unchanged in Q2 2025.
  • ANI Pharmaceuticals made up ﹤0.01% of Moser Wealth Advisors's portfolio in Q2 2025, its #192 holding.
  • Moser Wealth Advisors first reported a position in ANI Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • Moser Wealth Advisors's ANI Pharmaceuticals position peaked at $1K in Q1 2025.
  • 232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.

Based on Moser Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.